v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:    
Research and development $ 28,429 $ 18,705
General and administrative 11,946 11,181
Total operating expenses 40,375 29,886
Other (income) expense (354) 626
Loss before provision (benefit) for income taxes (40,021) (30,512)
Provision (benefit) for income taxes 352 (41)
Net loss $ (40,373) $ (30,471)
Net loss per common share - basic (in dollars per share) $ (0.35) $ (0.31)
Net loss per common share - diluted (in dollars per share) $ (0.35) $ (0.31)
Weighted-average common shares outstanding – basic (in shares) 116,557,508 97,976,982
Weighted-average common shares outstanding – diluted (in shares) 116,557,508 97,976,982

Source